KULVINDER KOCHAR KAUR, MD; GAUTAM ALLAHBADIA, MD, DNB; MANDEEP SINGH, MD, DM. Improved Management of Type 2 Diabetes Mellitus with Empigliflozin and Hypertension with Renin-Angiotensin System Inhibitors and Manidipine, Preferentially of Dihydropyridones to Optimize Cardiovascular Outcomes. Obesity Research, [S. l.], p. 1–13, 2025. DOI: 10.17140/oroj.2025.v11.i01.pp01-13.1425. Disponível em: https://openventio.us/index.php/OR/article/view/1425. Acesso em: 23 oct. 2026.